Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 6/20 | 0.47 |
| ▸ | MAOB | P27338 | 6/20 | 0.47 |
| ▸ | EGFR | P00533 | 2/20 | 0.37 |
| ▸ | MAPT | P10636 | 2/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | XBP1 | P17861 | 1/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12997576 | 0.84 | ACHE (0.34) | MAOAMAOBMEN1KMT2AATM | |
| SCHEMBL3747872 | 0.83 | MAOA (0.48) | MAOAMAOBEGFRMAPTALDH1A1 | |
| SCHEMBL28598605 | 0.78 | MAOA (0.44) | MAOAMAOBMAPTMEN1KMT2A | |
| SCHEMBL28916093 | 0.78 | MAOA (0.50) | MAOAMAOBMAPTALDH1A1LMNA | |
| SCHEMBL28583017 | 0.78 | MAOA (0.50) | MAOAMAOBLMNASMN1; SMN2 | |
| SCHEMBL8189072 | 0.78 | MAOA (0.48) | MAOAMAOBEGFRMAPTALDH1A1 | |
| SCHEMBL8383505 | 0.78 | MAOA (0.44) | MAOAMAOBEGFRMAPTALDH1A1 | |
| SCHEMBL16687344 | 0.78 | SMN1; SMN2 (0.32) | ATMSMN1; SMN2 | |
| SCHEMBL3183060 | 0.77 | MAOA (0.52) | MAOAMAOBMAPTALDH1A1MEN1 | |
| SCHEMBL28059511 | 0.77 | MAOA (0.42) | MAOAMAOBEGFRMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 34 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113024349-A | 3, 3-difluoro-1, 5-hexadiene compound and preparation method and application thereof | 南京工业大学 | 2021-06-25 | — | — | CN | claimed |
| JP-62209117-A | — | — | None | — | — | JP | disclosed |
| EP-4495125-A1 | A CATALYST FREE SYNTHESIS METHOD FOR INTRODUCING A TRIFLUOROMETHOXY MOIETY INTO AT LEAST ONE ORGANIC COMPOUND | Freie Universität Berlin (DE) | 2025-01-22 | — | — | EP | disclosed |
| CN-113024349-B | 3, 3-difluoro-1, 5-hexadiene compound and preparation method and application thereof | 南京工业大学 | 2022-06-07 | — | — | CN | disclosed |
| CN-113024349-A | 3, 3-difluoro-1, 5-hexadiene compound and preparation method and application thereof | 南京工业大学 | 2021-06-25 | — | — | CN | disclosed |
| US-8809567-B2 | Method for producing silylenol ethers | KYOTO UNIVERSITY (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8809567-B2 | Method for producing silylenol ethers | KYOTO UNIVERSITY (JP) | 2014-08-19 | — | — | US | disclosed |
| US-8809567-B2 | Method for producing silylenol ethers | KYOTO UNIVERSITY (JP) | 2014-08-19 | — | — | US | disclosed |
| US-20130053567-A1 | METHOD FOR PRODUCING SILYLENOL ETHERS | KYOTO UNIVERSITY (JP) | 2013-02-28 | — | — | US | disclosed |
| US-20130053567-A1 | METHOD FOR PRODUCING SILYLENOL ETHERS | KYOTO UNIVERSITY (JP) | 2013-02-28 | — | — | US | disclosed |
| WO-1999020267-A1 | FURANYL, TETRACYCLIC TRITERPENE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | MERCK & CO., INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| WO-1999020274-A1 | TETRACYCLIC TRITERPENE DERIVATIVES WITH IMMUNOSUPPRESSANT ACTIVITY | MERCK & CO., INC. (US) | 1999-04-29 | — | — | WO | disclosed |
| US-5879855-A | PIGMENT PRECURSOR DISSOLVED IN COMPOSITION WHICH CAN BE TRANSFORMED TO INSOLUBLE PIGMENT, POSITIVE OR NEGATIVE PHOTORESIST WHICH CAN BE MODIFIED | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-03-09 | — | — | US | disclosed |
| US-5871670-A | Electroconductive composition | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1999-02-16 | — | — | US | disclosed |
| US-5830267-A | Coloration of high molecular weight organic materials in the mass with soluble phthalocyanine precursors | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-11-03 | — | — | US | disclosed |
| EP-0782750-A1 | NOVEL ELECTROCONDUCTIVE COMPOSITION | Ciba SC Holding AG (CH) | 1997-07-09 | — | — | EP | disclosed |
| EP-0742255-A1 | Colouration of high molecular weight organic materials in the mass with soluble phthalocyanine precursors | CIBA-GEIGY AG (CH) | 1996-11-13 | — | — | EP | disclosed |
| WO-1996009629-A1 | NOVEL ELECTROCONDUCTIVE COMPOSITION | CIBA SPECIALTY CHEMICALS HOLDIING INC (CH) | 1996-03-28 | — | — | WO | disclosed |
| EP-0654711-A1 | Compositions for making structured color images and application thereof | CIBA-GEIGY AG (CH) | 1995-05-24 | — | — | EP | disclosed |
| JP-S62209117-A | NOVEL COPOLYMER AND PRODUCTION THEREOF | TSURUTA TEIJI | 1987-09-14 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130053567-A1 | METHOD FOR PRODUCING SILYLENOL ETHERS | AKR7A2, MSMO1, CYP2E1 | MAOA 2523/4885MAOB 2747/4885EGFR 2118/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.